S. Korean firm acquires Pharmexa unit
SEOUL, Oct. 31 (Yonhap) -- Kael Co., a South Korean biotechnology start-up, said Friday it has acquired Gemvax, a unit of Danish cancer-vaccine maker Pharmexa A/S.
SEOUL, Oct. 31 (Yonhap) -- Kael Co., a South Korean biotechnology start-up, said Friday it has acquired Gemvax, a unit of Danish cancer-vaccine maker Pharmexa A/S.
SEOUL, Oct.
All information carried by the Yonhap News Agency, including articles,
SEOUL, Oct.
SEOUL, Oct. 31 (Yonhap) -- South Korean stocks opened slightly lower Friday but soon gained ground as foreign and retail investors were heartened by overnight Wall Street gains, analysts said.
KOSDAQ 299.86 UP 3.81 points (open)
(END)
KOSPI 1,083.14 DN 1.58 points (open)
(END)